Artículos científicos

1. Perez-Rando M, Elvira UKA, García-Martí G, Gadea M, Aguilar EJ, Escarti MJ, Ahulló-Fuster MA, Grasa E, Corripio I, Sanjuan J, Nacher J. Alterations in the volume of thalamic nuclei in patients with schizophrenia and persistent auditory hallucinations. Neuroimage Clin. 2022 Jun 1;35:103070.
   https://pubmed.ncbi.nlm.nih.gov/35667173/
2. Sanjuán J, Castro-Martínez XH, García-Martí G, González-Fernández J, Sanz-Requena R, Haro JM, Meana JJ, Martí-Bonmatí L, Nacher J, Sebastiá-Ortega N, Gilabert-Juan J, Moltó MD. FOXP2 expression and gray matter density in the male brains of patients with schizophrenia. Brain Imaging Behav. 2021 Jun;15(3):1403-1411.
   https://pubmed.ncbi.nlm.nih.gov/32734433/
3. González-Vivas C, García-Martí G, Soldevila-Matías P, Sanz-Requena R, Aguilar EJ, Castro-Bleda MJ, Martí-Bonmatí L, Sanjuan J. First-Episode Psychotic Patients Showed Longitudinal Brain Changes Using fMRI With an Emotional Auditory Paradigm. Front Psychiatry. 2020 Dec 11;11:593042. doi: 10.3389/fpsyt.2020.593042. PMID: 33424663; PMCID: PMC7794005.
   https://pubmed.ncbi.nlm.nih.gov/33424663/
4. Pina-Camacho L, Del Rey-Mejías Á, Janssen J, Bioque M, González-Pinto A, Arango C, Lobo A, Sarró S, Desco M, Sanjuan J, Lacalle-Aurioles M, Cuesta MJ, Saiz-Ruiz J, Bernardo M, Parellada M; PEPs Group. Age at First Episode Modulates Diagnosis-Related Structural Brain Abnormalities in Psychosis. Schizophr Bull. 2016 Mar;42(2):344-57.
   https://pubmed.ncbi.nlm.nih.gov/26371339/
5. de la Iglesia-Vaya M, Escartí MJ, Molina-Mateo J, Martí-Bonmatí L, Gadea M, Castellanos FX, Aguilar García-Iturrospe EJ, Robles M, Biswal BB, Sanjuan J. Abnormal synchrony and effective connectivity in patients with schizophrenia and auditory hallucinations. Neuroimage Clin. 2014 Sep 4;6:171-9. doi: 10.1016/j.nicl.2014.08.027. PMID: 25379429; PMCID: PMC4215518.
   https://pubmed.ncbi.nlm.nih.gov/25379429/
6. González-Vivas C, et al (Sanjuan J) Longitudinal studies of functional magnetic resonance imaging in first-episode psychosis: A systematic review. Eur Psychiatry. 2019 Jun;59:60-69. doi: 10.1016/j.eurpsy.2019.04.009. Epub 2019 May 7. PMID: 31075523.
7. González-Vivas C, (Sanjuan J) First-Episode Psychotic Patients Showed Longitudinal Brain Changes Using fMRI With an Emotional Auditory Paradigm. Front Psychiatry. 2020 Dec 11;11:593042. doi: 10.3389/fpsyt.2020.593042. PMID: 33424663; PMCID: PMC7794005.
8. Soldevila-Matías P, et al (Sanjuan J) Neuroimaging correlates of insight in non-affective psychosis: A systematic review and meta-analysis. Rev Psiquiatr Salud Ment (Engl Ed). 2021 Jul 13:S1888-9891(21)00067-7. English, Spanish. doi: 10.1016/j.rpsm.2021.07.001. Epub ahead of print. PMID: 34271162.
9. Soldevila-Matías P, et al (Sanjuan J) Precuneus and insular hypoactivation during cognitive processing in first-episode psychosis: Systematic review and meta-analysis of fMRI studies. Rev Psiquiatr Salud Ment (Engl Ed). 2020 Sep 25:S1888-9891(20)30100-2. English, Spanish. doi: 10.1016/j.rpsm.2020.08.001. Epub ahead of print. PMID: 32988773.
10. Pina-Camacho L, et al (Sanjuan J) Age at First Episode Modulates Diagnosis-Related Structural Brain Abnormalities in Psychosis. Schizophr Bull. 2016 Mar;42(2):344-57. doi: 10.1093/schbul/sbv128. Epub 2015 Sep 14. PMID: 26371339; PMCID: PMC4753597.
11. Sanjuan J, Lull JJ, Aguilar EJ, Martí-Bonmatí L, Moratal D, Gonzalez JC, Robles M, Keshavan MS. Emotional words induce enhanced brain activity in schizophrenic patients with auditory hallucinations. Psychiatry Res. 2007 Jan 15;154(1):21-9. doi: 10.1016/j.pscychresns.2006.04.011. Epub 2006 Dec 20. PMID: 17184978.

1. Fusar-Poli L, Pries LK, van Os J, Erzin G, Delespaul P, Kenis G, Luykx JJ, Lin BD, Richards AL, Akdede B, Binbay T, Altınyazar V, Yalınçetin B, Gümüş-Akay G, Cihan B, Soygür H, Ulaş H, Cankurtaran EŞ, Kaymak SU, Mihaljevic MM, Andric-Petrovic S, Mirjanic T, Bernardo M, Mezquida G, Amoretti S, Bobes J, Saiz PA, García-Portilla MP, Sanjuan J, Aguilar EJ, Santos JL, Jiménez-López E, Arrojo M, Carracedo A, López G, González-Peñas J, Parellada M, Maric NP, Atbaşoğlu C, Üçok A, Alptekin K, Saka MC; Genetic Risk and Outcome of Psychosis (GROUP) investigators, Aguglia E, Arango C, O’Donovan M, Rutten BPF, Guloksuz S. Examining facial emotion recognition as an intermediate phenotype for psychosis: Findings from the EUGEI study. Prog Neuropsychopharmacol Biol Psychiatry. 2022 Mar 8;113:110440.
   https://pubmed.ncbi.nlm.nih.gov/34536513/
2. Quattrone D, Reininghaus U, Richards AL, Tripoli G, Ferraro L, Quattrone A, Marino P, Rodriguez V, Spinazzola E, Gayer-Anderson C, Jongsma HE, Jones PB, La Cascia C, La Barbera D, Tarricone I, Bonora E, Tosato S, Lasalvia A, Szöke A, Arango C, Bernardo M, Bobes J, Del Ben CM, Menezes PR, Llorca PM, Santos JL, Sanjuán J, Arrojo M, Tortelli A, Velthorst E, Berendsen S, de Haan L, Rutten BPF, Lynskey MT, Freeman TP, Kirkbride JB, Sham PC, O’Donovan MC, Cardno AG, Vassos E, van Os J, Morgan C, Murray RM, Lewis CM, Di Forti M; EU-GEI collaborators. The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study. Transl Psychiatry. 2021 Aug 10;11(1):423.
   https://pubmed.ncbi.nlm.nih.gov/34376640/
3. Pries LK, Dal Ferro GA, van Os J, Delespaul P, Kenis G, Lin BD, Luykx JJ, Richards AL, Akdede B, Binbay T, Altınyazar V, Yalınçetin B, Gümüş-Akay G, Cihan B, Soygür H, Ulaş H, Şahin Cankurtaran E, Ulusoy Kaymak S, Mihaljevic MM, Andric Petrovic S, Mirjanic T, Bernardo M, Mezquida G, Amoretti S, Bobes J, Saiz PA, García-Portilla MP, Sanjuan J, Aguilar EJ, Santos JL, Jiménez-López E, Arrojo M, Carracedo A, López G, González-Peñas J, Parellada M, Maric NP, Atbaşoğlu C, Ucok A, Alptekin K, Can Saka M; Genetic Risk and Outcome of Psychosis (GROUP) investigators, Arango C, O’Donovan M, Tosato S, Rutten BPF, Guloksuz S. Examining the independent and joint effects of genomic and exposomic liabilities for schizophrenia across the psychosis spectrum. Epidemiol Psychiatr Sci. 2020 Nov 17;29:e182. doi: 10.1017/S2045796020000943. PMID: 33200977; PMCID: PMC7681168.
   https://pubmed.ncbi.nlm.nih.gov/33200977/
4. Guloksuz S, Pries LK, Delespaul P, Kenis G, Luykx JJ, Lin BD, Richards AL, Akdede B, Binbay T, Altınyazar V, Yalınçetin B, Gümüş-Akay G, Cihan B, Soygür H, Ulaş H, Cankurtaran E, Kaymak SU, Mihaljevic MM, Petrovic SA, Mirjanic T, Bernardo M, Cabrera B, Bobes J, Saiz PA, García-Portilla MP, Sanjuan J, Aguilar EJ, Santos JL, Jiménez-López E, Arrojo M, Carracedo A, López G, González-Peñas J, Parellada M, Maric NP, Atbaşog Lu C, Ucok A, Alptekin K, Saka MC; Genetic Risk and Outcome of Psychosis (GROUP) investigators, Arango C, O’Donovan M, Rutten BPF, van Os J. Examining the independent and joint effects of molecular genetic liability and environmental exposures in schizophrenia: results from the EUGEI study. World Psychiatry. 2019 Jun;18(2):173-182.
   https://pubmed.ncbi.nlm.nih.gov/31059627/
5. European Network of National Networks studying Gene-Environment Interactions in Schizophrenia (EU-GEI), van Os J, Rutten BP, Myin-Germeys I, Delespaul P, Viechtbauer W, van Zelst C, Bruggeman R, Reininghaus U, Morgan C, Murray RM, Di Forti M, McGuire P, Valmaggia LR, Kempton MJ, Gayer-Anderson C, Hubbard K, Beards S, Stilo SA, Onyejiaka A, Bourque F, Modinos G, Tognin S, Calem M, O’Donovan MC, Owen MJ, Holmans P, Williams N, Craddock N, Richards A, Humphreys I, Meyer-Lindenberg A, Leweke FM, Tost H, Akdeniz C, Rohleder C, Bumb JM, Schwarz E, Alptekin K, Üçok A, Saka MC, Atbaşoğlu EC, Gülöksüz S, Gumus-Akay G, Cihan B, Karadağ H, Soygür H, Cankurtaran EŞ, Ulusoy S, Akdede B, Binbay T, Ayer A, Noyan H, Karadayı G, Akturan E, Ulaş H, Arango C, Parellada M, Bernardo M, Sanjuán J, Bobes J, Arrojo M, Santos JL, Cuadrado P, Rodríguez Solano JJ, Carracedo A, García Bernardo E, Roldán L, López G, Cabrera B, Cruz S, Díaz Mesa EM, Pouso M, Jiménez E, Sánchez T, Rapado M, González E, Martínez C, Sánchez E, Olmeda MS, de Haan L, Velthorst E, van der Gaag M, Selten JP, van Dam D, van der Ven E, van der Meer F, Messchaert E, Kraan T, Burger N, Leboyer M, Szoke A, Schürhoff F, Llorca PM, Jamain S, Tortelli A, Frijda F, Vilain J, Galliot AM, Baudin G, Ferchiou A, Richard JR, Bulzacka E, Charpeaud T, Tronche AM, De Hert M, van Winkel R, Decoster J, Derom C, Thiery E, Stefanis NC, Sachs G, Aschauer H, Lasser I, Winklbaur B, Schlögelhofer M, Riecher-Rössler A, Borgwardt S, Walter A, Harrisberger F, Smieskova R, Rapp C, Ittig S, Soguel-dit-Piquard F, Studerus E, Klosterkötter J, Ruhrmann S, Paruch J, Julkowski D, Hilboll D, Sham PC, Cherny SS, Chen EY, Campbell DD, Li M, Romeo-Casabona CM, Emaldi Cirión A, Urruela Mora A, Jones P, Kirkbride J, Cannon M, Rujescu D, Tarricone I, Berardi D, Bonora E, Seri M, Marcacci T, Chiri L, Chierzi F, Storbini V, Braca M, Minenna MG, Donegani I, Fioritti A, La Barbera D, La Cascia CE, Mulè A, Sideli L, Sartorio R, Ferraro L, Tripoli G, Seminerio F, Marinaro AM, McGorry P, Nelson B, Amminger GP, Pantelis C, Menezes PR, Del-Ben CM, Gallo Tenan SH, Shuhama R, Ruggeri M, Tosato S, Lasalvia A, Bonetto C, Ira E, Nordentoft M, Krebs MO, Barrantes-Vidal N, Cristóbal P, Kwapil TR, Brietzke E, Bressan RA, Gadelha A, Maric NP, Andric S, Mihaljevic M, Mirjanic T. Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations. Schizophr Bull. 2014
   https://pubmed.ncbi.nlm.nih.gov/24860087/
6. Steinberg S, de Jong S, Mattheisen M, Costas J, Demontis D, Jamain S, Pietiläinen OP, Lin K, Papiol S, Huttenlocher J, Sigurdsson E, Vassos E, Giegling I, Breuer R, Fraser G, Walker N, Melle I, Djurovic S, Agartz I, Tuulio-Henriksson A, Suvisaari J, Lönnqvist J, Paunio T, Olsen L, Hansen T, Ingason A, Pirinen M, Strengman E; GROUP, Hougaard DM, Orntoft T, Didriksen M, Hollegaard MV, Nordentoft M, Abramova L, Kaleda V, Arrojo M, Sanjuán J, Arango C, Etain B, Bellivier F, Méary A, Schürhoff F, Szoke A, Ribolsi M, Magni V, Siracusano A, Sperling S, Rossner M, Christiansen C, Kiemeney LA, Franke B, van den Berg LH, Veldink J, Curran S, Bolton P, Poot M, Staal W, Rehnstrom K, Kilpinen H, Freitag CM, Meyer J, Magnusson P, Saemundsen E, Martsenkovsky I, Bikshaieva I, Martsenkovska I, Vashchenko O, Raleva M, Paketchieva K, Stefanovski B, Durmishi N, Pejovic Milovancevic M, Lecic Tosevski D, Silagadze T, Naneishvili N, Mikeladze N, Surguladze S, Vincent JB, Farmer A, Mitchell PB, Wright A, Schofield PR, Fullerton JM, Montgomery GW, Martin NG, Rubino IA, van Winkel R, Kenis G, De Hert M, Réthelyi JM, Bitter I, Terenius L, Jönsson EG, Bakker S, van Os J, Jablensky A, Leboyer M, Bramon E, Powell J, Murray R, Corvin A, Gill M, Morris D, O’Neill FA, Kendler K, Riley B; Wellcome Trust Case Control Consortium 2, Craddock N, Owen MJ, O’Donovan MC, Thorsteinsdottir U, Kong A, Ehrenreich H, Carracedo A, Golimbet V, Andreassen OA, Børglum AD, Mors O, Mortensen PB, Werge T, Ophoff RA, Nöthen MM, Rietschel M, Cichon S, Ruggeri M, Tosato S, Palotie A, St Clair D, Rujescu D, Collier DA, Stefansson H, Stefansson K. Common variant at 16p11.2 conferring risk of psychosis. Mol Psychiatry. 2014 Jan;19(1):108-14.
   https://pubmed.ncbi.nlm.nih.gov/23164818/
7. Steinberg S, de Jong S; Irish Schizophrenia Genomics Consortium, Andreassen OA, Werge T, Børglum AD, Mors O, Mortensen PB, Gustafsson O, Costas J, Pietiläinen OP, Demontis D, Papiol S, Huttenlocher J, Mattheisen M, Breuer R, Vassos E, Giegling I, Fraser G, Walker N, Tuulio-Henriksson A, Suvisaari J, Lönnqvist J, Paunio T, Agartz I, Melle I, Djurovic S, Strengman E; GROUP, Jürgens G, Glenthøj B, Terenius L, Hougaard DM, Ørntoft T, Wiuf C, Didriksen M, Hollegaard MV, Nordentoft M, van Winkel R, Kenis G, Abramova L, Kaleda V, Arrojo M, Sanjuán J, Arango C, Sperling S, Rossner M, Ribolsi M, Magni V, Siracusano A, Christiansen C, Kiemeney LA, Veldink J, van den Berg L, Ingason A, Muglia P, Murray R, Nöthen MM, Sigurdsson E, Petursson H, Thorsteinsdottir U, Kong A, Rubino IA, De Hert M, Réthelyi JM, Bitter I, Jönsson EG, Golimbet V, Carracedo A, Ehrenreich H, Craddock N, Owen MJ, O’Donovan MC; Wellcome Trust Case Control Consortium 2, Ruggeri M, Tosato S, Peltonen L, Ophoff RA, Collier DA, St Clair D, Rietschel M, Cichon S, Stefansson H, Rujescu D, Stefansson K. Common variants at VRK2 and TCF4 conferring risk of schizophrenia. Hum Mol Genet. 2011 Oct 15;20(20):4076-81.
   https://pubmed.ncbi.nlm.nih.gov/21791550/
8. Rivero O, Reif A, Sanjuán J, Moltó MD, Kittel-Schneider S, Nájera C, Töpner T, Lesch KP. Impact of the AHI1 gene on the vulnerability to schizophrenia: a case-control association study. PLoS One. 2010 Aug 18;5(8):e12254.
   https://pubmed.ncbi.nlm.nih.gov/20805890/
9. Tolosa A, Sanjuán J, Dagnall AM, Moltó MD, Herrero N, de Frutos R. FOXP2 gene and language impairment in schizophrenia: association and epigenetic studies. BMC Med Genet. 2010 Jul 22;11:114.
   https://pubmed.ncbi.nlm.nih.gov/20649982/
10. Rivero O, Sanjuan J, Aguilar EJ, Gonzalez JC, Molto MD, de Frutos R, Najera C. Serotonin transporter gene polymorphisms and auditory hallucinations in psychosis. Rev Neurol. 2010 Mar 16;50(6):325-32.
    https://pubmed.ncbi.nlm.nih.gov/20309830/
11. Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu D, Werge T, Pietiläinen OP, Mors O, Mortensen PB, Sigurdsson E, Gustafsson O, Nyegaard M, Tuulio-Henriksson A, Ingason A, Hansen T, Suvisaari J, Lonnqvist J, Paunio T, Børglum AD, Hartmann A, Fink-Jensen A, Nordentoft M, Hougaard D, Norgaard-Pedersen B, Böttcher Y, Olesen J, Breuer R, Möller HJ, Giegling I, Rasmussen HB, Timm S, Mattheisen M, Bitter I, Réthelyi JM, Magnusdottir BB, Sigmundsson T, Olason P, Masson G, Gulcher JR, Haraldsson M, Fossdal R, Thorgeirsson TE, Thorsteinsdottir U, Ruggeri M, Tosato S, Franke B, Strengman E, Kiemeney LA; Genetic Risk and Outcome in Psychosis (GROUP), Melle I, Djurovic S, Abramova L, Kaleda V, Sanjuan J, de Frutos R, Bramon E, Vassos E, Fraser G, Ettinger U, Picchioni M, Walker N, Toulopoulou T, Need AC, Ge D, Yoon JL, Shianna KV, Freimer NB, Cantor RM, Murray R, Kong A, Golimbet V, Carracedo A, Arango C, Costas J, Jönsson EG, Terenius L, Agartz I, Petursson H, Nöthen MM, Rietschel M, Matthews PM, Muglia P, Peltonen L, St Clair D, Goldstein DB, Stefansson K, Collier DA. Common variants conferring risk of schizophrenia. Nature. 2009 Aug 6;460(7256):744-7.
    https://pubmed.ncbi.nlm.nih.gov/19571808/
12. Trubetskoy V,et al (Sanjuan J) Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature. 2022 Apr;604(7906):502-508. doi: 10.1038/s41586-022-04434-5. Epub 2022 Apr 8. PMID: 35396580.
13. Alcaide J,(Sanjuan J) Alterations of perineuronal nets in the dorsolateral prefrontal cortex of neuropsychiatric patients. Int J Bipolar Disord. 2019 Nov 15;7(1):24. doi: 10.1186/s40345-019-0161-0. PMID: 31728775; PMCID: PMC6856240.
14. Guloksuz S, et al (Sanjuan J) Examining the independent and joint effects of molecular genetic liability and environmental exposures in schizophrenia: results from the EUGEI study. World Psychiatry. 2019 Jun;18(2):173-182. doi: 10.1002/wps.20629. PMID: 31059627; PMCID: PMC6502485.
15. Gassó P, et al (Sanjuan J)  Impact of NTRK2, DRD2 and ACE polymorphisms on prolactin levels in antipsychotic-treated patients with first-episode psychosis. J Psychopharmacol. 2018 Jun;32(6):702-710. doi: 10.1177/0269881118773026. Epub 2018 May 16. PMID: 29767567.
16. Ivorra JL,et al (Sanjuan J)  Replication of previous genome-wide association studies of psychiatric diseases in a large schizophrenia case-control sample from Spain. Schizophr Res. 2014 Oct;159(1):107-13. doi: 10.1016/j.schres.2014.07.004. Epub 2014 Aug 12. PMID: 25124521
17. European Network of National Networks studying Gene-Environment Interactions in Schizophrenia (EU-GEI), (Sanjuan J)  Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations. Schizophr Bull. 2014 Jul;40(4):729-36. doi: 10.1093/schbul/sbu069. Epub 2014 May 24. PMID: 24860087; PMCID: PMC4059449.
18. Carrera N, et al (Sanjuán J), Association study of nonsynonymous single nucleotide polymorphisms in schizophrenia. Biol Psychiatry. 2012 Jan 15;71(2):169-77. doi: 10.1016/j.biopsych.2011.09.032. Epub 2011 Nov 10. PMID: 22078303.
19. Gratacòs M, et al (Sanjuan J). Identification of new putative susceptibility genes for several psychiatric disorders by association analysis of regulatory and non-synonymous SNPs of 306 genes involved in neurotransmission and neurodevelopment. Am J Med Genet B Neuropsychiatr Genet. 2009 Sep 5;150B(6):808-16. doi: 10.1002/ajmg.b.30902. PMID: 19086053.

1. Jongsma HE, Gayer-Anderson C, Tarricone I, Velthorst E, van der Ven E, Quattrone D, di Forti M; EU-GEI WP2 Group, Menezes PR, Del-Ben CM, Arango C, Lasalvia A, Berardi D, La Cascia C, Bobes J, Bernardo M, Sanjuán J, Santos JL, Arrojo M, de Haan L, Tortelli A, Szöke A, Murray RM, Rutten BP, van Os J, Morgan C, Jones PB, Kirkbride JB. Social disadvantage, linguistic distance, ethnic minority status and first-episode psychosis: results from the EU-GEI case-control study. Psychol Med. 2021 Jul;51(9):1536-1548.
   https://pubmed.ncbi.nlm.nih.gov/32122439/
2. Pries LK, Lage-Castellanos A, Delespaul P, Kenis G, Luykx JJ, Lin BD, Richards AL, Akdede B, Binbay T, Altinyazar V, Yalinçetin B, Gümüş-Akay G, Cihan B, Soygür H, Ulaş H, Cankurtaran EŞ, Kaymak SU, Mihaljevic MM, Petrovic SA, Mirjanic T, Bernardo M, Cabrera B, Bobes J, Saiz PA, García-Portilla MP, Sanjuan J, Aguilar EJ, Santos JL, Jiménez-López E, Arrojo M, Carracedo A, López G, González-Peñas J, Parellada M, Maric NP, Atbaşoğlu C, Ucok A, Alptekin K, Saka MC; Genetic Risk and Outcome of Psychosis (GROUP) investigators, Arango C, O’Donovan M, Rutten BPF, van Os J, Guloksuz S. Estimating Exposome Score for Schizophrenia Using Predictive Modeling Approach in Two Independent Samples: The Results From the EUGEI Study. Schizophr Bull. 2019 Sep 11;45(5):960-965.
   https://pubmed.ncbi.nlm.nih.gov/31508804/
3. Ferraro L, La Cascia C, Quattrone D, Sideli L, Matranga D, Capuccio V, Tripoli G, Gayer-Anderson C, Morgan C, Sami MB, Sham P, de Haan L, Velthorst E, Jongsma HE, Kirkbride JB, Rutten BPF, Richards AL, Roldan L, Arango C, Bernardo M, Bobes J, Sanjuan J, Santos JL, Arrojo M, Tarricone I, Tortelli A, Szöke A, Del-Ben CM, Selten JP, Lynskey M, Jones PB, Van Os J, La Barbera D; WP2 EU-GEI GROUP, Murray RM, Di Forti M. Premorbid Adjustment and IQ in Patients With First-Episode Psychosis: A Multisite Case-Control Study of Their Relationship With Cannabis Use. Schizophr Bull. 2020 Apr 10;46(3):517-529.
   https://pubmed.ncbi.nlm.nih.gov/31361020/
4. Misra S, Gelaye B, Koenen KC, Williams DR, Borba CPC, Quattrone D, Di Forti M, La Cascia C, La Barbera D, Tarricone I, Berardi D, Szöke A, Arango C, Tortelli A, de Haan L, Velthorst E, Bobes J, Bernardo M, Sanjuán J, Santos JL, Arrojo M, Del-Ben CM, Menezes PR, Selten JP, Jones PB, Kirkbride JB; EU-GEI WP2 Group, Rutten BPF, van Os J, Murray RM, Gayer-Anderson C, Morgan C. Early Parental Death and Risk of Psychosis in Offspring: A Six-Country Case-Control Study. J Clin Med. 2019 Jul 23;8(7):1081. doi: 10.3390/jcm8071081. PMID: 31340495; PMCID: PMC6679091.
   https://pubmed.ncbi.nlm.nih.gov/31340495/
5. Jongsma HE, Gayer-Anderson C, Lasalvia A, Quattrone D, Mulè A, Szöke A, Selten JP, Turner C, Arango C, Tarricone I, Berardi D, Tortelli A, Llorca PM, de Haan L, Bobes J, Bernardo M, Sanjuán J, Santos JL, Arrojo M, Del-Ben CM, Menezes PR, Velthorst E, Murray RM, Rutten BP, Jones PB, van Os J, Morgan C, Kirkbride JB; European Network of National Schizophrenia Networks Studying Gene-Environment Interactions Work Package 2 (EU-GEI WP2) Group. Treated Incidence of Psychotic Disorders in the Multinational EU-GEI Study. JAMA Psychiatry. 2018 Jan 1;75(1):36-46.
   https://pubmed.ncbi.nlm.nih.gov/29214289/
6. Sideli L, et al (Sanjuan J). Childhood Maltreatment, Educational Attainment, and IQ: Findings From a Multicentric Case-control Study of First-episode Psychosis (EU-GEI). Schizophr Bull. 2022 May 7;48(3):575-589. doi: 10.1093/schbul/sbac004. PMID: 35137235; PMCID: PMC9077421.
7. Misra S, et al (Sanjuan J) Perceived major experiences of discrimination, ethnic group, and risk of psychosis in a six-country case-control study. Psychol Med. 2021 Mar 2:1-9. doi: 10.1017/S0033291721000453. Epub ahead of print. PMID: 33648622.
8. van Os J, et al (Sanjuan J). Evidence, and replication there of, that molecular-genetic and environmental risks for psychosis impact through an affective pathway. Psychol Med. 2020 Oct 19:1-13. doi: 10.1017/S0033291720003748. Epub ahead of print. PMID: 33070791.
9. Henquet C, et al (Sanjuan J) A replication study of JTC bias, genetic liability for psychosis and delusional ideation. Psychol Med. 2020 Oct 13:1-7. doi: 10.1017/S0033291720003578. Epub ahead of print. PMID: 33046166.
10. Termorshuizen F, et al (Sanjuan J) The incidence of psychotic disorders among migrants and minority ethnic groups in Europe: findings from the multinational EU-GEI study. Psychol Med. 2022 May;52(7):1376-1385. doi: 10.1017/S0033291720003219. Epub 2020 Sep 22. PMID: 32958094; PMCID: PMC9157293.
11. Cuesta MJ, et al (Sanjuan J)  Motor abnormalities and basal ganglia in first-episode psychosis (FEP). Psychol Med. 2021 Jul;51(10):1625-1636. doi: 10.1017/S0033291720000343. Epub 2020 Mar 2. PMID: 32114994.
12. Misra S, et al (Sanjuan J)  Early Parental Death and Risk of Psychosis in Offspring: A Six-Country Case-Control Study. J Clin Med. 2019 Jul 23;8(7):1081. doi: 10.3390/jcm8071081. PMID: 31340495; PMCID: PMC6679091.
13. Di Forti M, et al (Sanjuan J)  . The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study. Lancet Psychiatry. 2019 May;6(5):427-436. doi: 10.1016/S2215-0366(19)30048-3. Epub 2019 Mar 19. PMID: 30902669; PMCID: PMC7646282
14. Fraguas D, et al (Sanjuan J); Gene-environment interaction as a predictor of early adjustment in first episode psychosis. Schizophr Res. 2017 Nov;189:196-203. doi: 10.1016/j.schres.2017.02.021. Epub 2017 Mar 2. PMID: 28262436.
15. Bernardo M, et al (Sanjuan J). Modelling gene-environment interaction in first episodes of psychosis. Schizophr Res. 2017 Nov;189:181-189. doi: 10.1016/j.schres.2017.01.058. Epub 2017 Feb 5. PMID: 28179063.

1. Ferraro L, La Cascia C, La Barbera D, Sanchez-Gutierrez T, Tripoli G, Seminerio F, Sartorio C, Marrazzo G, Sideli L, Arango C, Arrojo M, Bernardo M, Bobes J, Del-Ben CM, Gayer-Anderson C, Jongsma HE, Kirkbride JB, Lasalvia A, Tosato S, Llorca PM, Menezes PR, Rutten BP, Santos JL, Sanjuán J, Selten JP, Szöke A, Tarricone I, Muratori R, Tortelli A, Velthorst E, Rodriguez V, Quattrone A, Jones PB, Van Os J, Vassos E, Morgan C, de Haan L, Reininghaus U, Cardno AG, Di Forti M, Murray RM, Quattrone D. The relationship of symptom dimensions with premorbid adjustment and cognitive characteristics at first episode psychosis: Findings from the EU-GEI study. Schizophr Res. 2021 Oct;236:69-79. doi: 10.1016/j.schres.2021.08.008.
   https://pubmed.ncbi.nlm.nih.gov/34403965/
2. Fusar-Poli L, Pries LK, van Os J, Radhakrishnan R, Pençe AY, Erzin G, Delespaul P, Kenis G, Luykx JJ, Lin BD, Akdede B, Binbay T, Altınyazar V, Yalınçetin B, Gümüş-Akay G, Cihan B, Soygür H, Ulaş H, Cankurtaran EŞ, Kaymak SU, Mihaljevic MM, Andric-Petrovic S, Mirjanic T, Bernardo M, Mezquida G, Amoretti S, Bobes J, Saiz PA, García-Portilla MP, Sanjuan J, Aguilar EJ, Santos JL, Jiménez-López E, Arrojo M, Carracedo A, López G, González-Peñas J, Parellada M, Maric NP, Atbaşoğlu C, Üçok A, Alptekin K, Saka MC; Genetic Risk and Outcome of Psychosis (GROUP) investigators, Aguglia E, Arango C, Rutten BP, Guloksuz S. The association between cannabis use and facial emotion recognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI study. Eur Neuropsychopharmacol. 2022 Aug 30;63:47-59. doi: 10.1016/j.euroneuro.2022.08.003. Epub ahead of print. PMID: 36055075. https://pubmed.ncbi.nlm.nih.gov/36055075/
3. Ajnakina O, Rodriguez V, Quattrone D, di Forti M, Vassos E, Arango C, Berardi D, Bernardo M, Bobes J, de Haan L, Del-Ben CM, Gayer-Anderson C, Jongsma HE, Lasalvia A, Tosato S, Llorca PM, Menezes PR, Rutten BP, Santos JL, Sanjuán J, Selten JP, Szöke A, Tarricone I, D’Andrea G, Richards A, Tortelli A, Velthorst E, Jones PB, Arrojo Romero M, La Cascia C, Kirkbride JB, van Os J, O’Donovan M, Murray RM; EU-GEI WP2 Group. Duration of Untreated Psychosis in First-Episode Psychosis is not Associated With Common Genetic Variants for Major Psychiatric Conditions: Results From the Multi-Center EU-GEI Study. Schizophr Bull. 2021 Oct 21;47(6):1653-1662.
   https://pubmed.ncbi.nlm.nih.gov/33963865/
4. Erzin G, Pries LK, van Os J, Fusar-Poli L, Delespaul P, Kenis G, Luykx JJ, Lin BD, Richards AL, Akdede B, Binbay T, Altınyazar V, Yalınçetin B, Gümüş-Akay G, Cihan B, Soygür H, Ulaş H, Cankurtaran EŞ, Kaymak SU, Mihaljevic MM, Andric-Petrovic S, Mirjanic T, Bernardo M, Mezquida G, Amoretti S, Bobes J, Saiz PA, García-Portilla MP, Sanjuan J, Aguilar EJ, Santos JL, Jiménez-López E, Arrojo M, Carracedo A, López G, González-Peñas J, Parellada M, Maric NP, Atbaşoğlu C, Ucok A, Alptekin K, Saka MC; Genetic Risk and Outcome of Psychosis (GROUP) investigators, Arango C, O’Donovan MC, Rutten BPF, Guloksuz S. Examining the association between exposome score for schizophrenia and functioning in schizophrenia, siblings, and healthy controls: Results from the EUGEI study. Eur Psychiatry. 2021 Mar 19;64(1):e25.
   https://pubmed.ncbi.nlm.nih.gov/33736735/
5. Tripoli G, Quattrone D, Ferraro L, Gayer-Anderson C, Rodriguez V, La Cascia C, La Barbera D, Sartorio C, Seminerio F, Tarricone I, Berardi D, Szöke A, Arango C, Tortelli A, Llorca PM, de Haan L, Velthorst E, Bobes J, Bernardo M, Sanjuán J, Santos JL, Arrojo M, Del-Ben CM, Menezes PR, Selten JP; EU-GEI WP2 Group, Jones PB, Jongsma HE, Kirkbride JB, Lasalvia A, Tosato S, Richards A, O’Donovan M, Rutten BP, Os JV, Morgan C, Sham PC, Murray RM, Murray GK, Di Forti M. Jumping to conclusions, general intelligence, and psychosis liability: findings from the multi-centre EU-GEI case-control study. Psychol Med. 2021 Mar;51(4):623-633. doi: 10.1017/S003329171900357X. Epub 2020 Apr 24. PMID: 32327005; PMCID: PMC8020493.
   https://pubmed.ncbi.nlm.nih.gov/32327005/
6. Schepers E, Lousberg R, Guloksuz S, Pries LK, Delespaul P, Kenis G, Luykx JJ, Lin BD, Richards AL, Akdede B, Binbay T, Altınyazar V, Yalınçetin B, Gümüş-Akay G, Cihan B, Soygür H, Ulaş H, Şahin Cankurtaran E, Ulusoy Kaymak S, Mihaljevic MM, Andric Petrovic S, Mirjanic T, Bernardo M, Cabrera B, Bobes J, Saiz PA, García-Portilla MP, Sanjuan J, Aguilar EJ, Luis Santos J, Jiménez-López E, Arrojo M, Carracedo A, López G, González-Peñas J, Parellada M, Maric NP, Atbaşoğlu C, Ucok A, Alptekin K, Can Saka M, Arango C, Rutten BPF, van Os J. White Noise Speech Illusions: A Trait-Dependent Risk Marker for Psychotic Disorder? Front Psychiatry. 2019 Sep 25;10:676. doi: 10.3389/fpsyt.2019.00676. PMID: 31607966; PMCID: PMC6774265.
   https://pubmed.ncbi.nlm.nih.gov/3160796
7. Quattrone D, Di Forti M, Gayer-Anderson C, Ferraro L, Jongsma HE, Tripoli G, La Cascia C, La Barbera D, Tarricone I, Berardi D, Szöke A, Arango C, Lasalvia A, Tortelli A, Llorca PM, de Haan L, Velthorst E, Bobes J, Bernardo M, Sanjuán J, Santos JL, Arrojo M, Del-Ben CM, Menezes PR, Selten JP; EU-GEI WP2 Group, Jones PB, Kirkbride JB, Richards AL, O’Donovan MC, Sham PC, Vassos E, Rutten BP, van Os J, Morgan C, Lewis CM, Murray RM, Reininghaus U. Transdiagnostic dimensions of psychopathology at first episode psychosis: findings from the multinational EU-GEI study. Psychol Med. 2019 Jun;49(8):1378-1391.
   https://pubmed.ncbi.nlm.nih.gov/30282569/
8. Ana Luengo, Olga Brotons, Esther Lorente, Neus Herrero, Eduardo J. Aguilar, María José Escartí, José Carlos González*, Carmen Leal, Julio Sanjuán Respuesta emocional ante estímulos  amenazantes en psicosis y trastornos de ansiedad Psychothema. 2009, vol 21, 1
   https://www.psicothema.com/pdf/3594.pdf
9. Sanjuán J, et a Subjective perception of cognitive deficit in psychotic patients. J Nerv Ment Dis. 2006 Jan;194(1):58-60. doi: 10.1097/01.nmd.0000195308.62107.31. PMID: 16462557.
10. Sanjuan J, et al Escala GEOPTE de cognición social para la psicosis [GEOPTE Scale of social cognition for psychosis]. Actas Esp Psiquiatr. 2003 May-Jun;31(3):120-8. Spanish. PMID: 12772039.
11. Tripoli G, et al (Sanjuan J) Facial Emotion Recognition in Psychosis and Associations With Polygenic Risk for Schizophrenia: Findings From the Multi-Center EU-GEI Case-Control Study. Schizophr Bull. 2022 Mar 23:sbac022. doi: 10.1093/schbul/sbac022. Epub ahead of print. PMID: 35325253.
12. Fusar-Poli L, et al (Sanjuan J). Examining facial emotion recognition as an intermediate phenotype for psychosis: Findings from the EUGEI study. Prog Neuropsychopharmacol Biol Psychiatry. 2022 Mar 8;113:110440. doi: 10.1016/j.pnpbp.2021.110440. Epub 2021 Sep 16. PMID: 34536513.
13. Ferraro L, et al (Sanjuan J) The relationship of symptom dimensions with premorbid adjustment and cognitive characteristics at first episode psychosis: Findings from the EU-GEI study. Schizophr Res. 2021 Oct;236:69-79. doi: 10.1016/j.schres.2021.08.008. Epub 2021 Aug 14. PMID: 34403965; PMCID: PMC8473991.
14. Quattrone D, , et al (Sanjuan J) The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study. Transl Psychiatry. 2021 Aug 10;11(1):423. doi: 10.1038/s41398-021-01526-0. PMID: 34376640; PMCID: PMC8355107.
15. Sastre-Buades A, et al (Sanjuan J )  Spanish Metacognition Study Group. Jumping to conclusions and suicidal behavior in depression and psychosis. J Psychiatr Res. 2021 May;137:514-520. doi: 10.1016/j.jpsychires.2021.03.024. Epub 2021 Mar 25. PMID: 33812324.
16. Erzin G,et al (Sanjuan J) Examining the association between exposome score for schizophrenia and functioning in schizophrenia, siblings, and healthy controls: Results from the EUGEI study. Eur Psychiatry. 2021 Mar 19;64(1):e25. doi: 10.1192/j.eurpsy.2021.19. PMID: 33736735; PMCID: PMC8080213.
17. Velthorst E, , et al (Sanjuan J) Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings. Mol Psychiatry. 2021 Aug;26(8):4529-4543. doi: 10.1038/s41380-020-00969-z. Epub 2021 Jan 7. PMID: 33414498.
18. Berendsen S, et al (Sanjuan J) Pre-training inter-rater reliability of clinical instruments in an international psychosis research project. Schizophr Res. 2021 Apr;230:104-107. doi: 10.1016/j.schres.2020.08.001. Epub 2020 Nov 24. PMID: 33243716.
19. Tripoli G,et al  (Sanjuan J)  . Jumping to conclusions, general intelligence, and psychosis liability: findings from the multi-centre EU-GEI case-control study. Psychol Med. 2021 Mar;51(4):623-633. doi: 10.1017/S003329171900357X. Epub 2020 Apr 24. PMID: 32327005; PMCID: PMC8020493.
20. Cuesta MJ,et al (Sanjuan J) Motor abnormalities and basal ganglia in first-episode psychosis (FEP). Psychol Med. 2021 Jul;51(10):1625-1636. doi: 10.1017/S0033291720000343. Epub 2020 Mar 2. PMID: 32114994.
21. González-Ortega I, et al (Sanjuan J). Influence of social cognition as a mediator between cognitive reserve and psychosocial functioning in patients with first episode psychosis. Psychol Med. 2020 Dec;50(16):2702-2710. doi: 10.1017/S0033291719002794. Epub 2019 Oct 22. PMID: 31637990.
22. Schepers E, et sal (Sanjuan J)  White Noise Speech Illusions: A Trait-Dependent Risk Marker for Psychotic Disorder? Front Psychiatry. 2019 Sep 25;10:676. doi: 10.3389/fpsyt.2019.00676. PMID: 31607966; PMCID: PMC6774265.
23. Cuesta MJ,(Sanjuan J)  Familial liability to schizophrenia and mood disorders and cognitive impairment in psychosis. Psychiatry Res. 2015 Jun 30;227(2-3):258-64. doi: 10.1016/j.psychres.2015.03.024. Epub 2015 Apr 2. PMID: 25908262.
24. Cuesta MJ,et al (Sanjuan J)  Premorbid adjustment and clinical correlates of cognitive impairment in first-episode psychosis. The PEPsCog Study. Schizophr Res. 2015 May;164(1-3):65-73. doi: 10.1016/j.schres.2015.02.022. Epub 2015 Mar 26. PMID: 25819935.
25. Martínez-Cengotitabengoa M, et al  (Sanjuan J) Cognitive impairment is related to oxidative stress and chemokine levels in first psychotic episodes. Schizophr Res. 2012 May;137(1-3):66-72. doi: 10.1016/j.schres.2012.03.004. Epub 2012 Mar 22. PMID: 22445462.

ALUCINACIONES

1. Sanjuan J, Aguilar EJ, Artigas F.  (2010) Pharmacological treatment of hallucinations. In Laroi F & Aleman A. Hallucinations. A guide to treatment and Management. Oxford. Oxford University Press. 

2. Sanjuan J, Lull JJ, Aguilar EJ, Martí-Bonmatí L, Moratal D, Gonzalez JC, Robles M, Keshavan MS. Emotional words induce enhanced brain activity in schizophrenic patients with auditory hallucinations. Psychiatry Res. 2007 Jan 15;154(1):21-9. doi: 10.1016/j.pscychresns.2006.04.011. Epub 2006 Dec 20. PMID: 17184978.

3.Sanjuan J. Etiopatogenia de las alucinaciones auditivas en las psicosis [The aetiopathogenesis of auditory hallucinations in psychosis]. Rev Neurol. 2006 Sep 1-15;43(5):280-6. Spanish. PMID: 16941426.

4.Sanjuán J, Lull JJ, Martí-Bonmati L, Aguilar EJ, Gadea M, Moratal-Pérez D, González JC, Robles M. Emotional auditory paradigm in neuroimaging: a base for the study of psychosis. Actas Esp Psiquiatr. 2005 Nov-Dec;33(6):383-9. PMID: 16292722.

5.Sanjuan J, Gonzalez JC, Aguilar EJ, Leal C, van Os J. Pleasurable auditory hallucinations. Acta Psychiatr Scand. 2004 Oct;110(4):273-8. doi: 10.1111/j.1600-0447.2004.00336.x. PMID: 15352928.

6.Sanjuan J, Toirac I, González JC, Leal C, Moltó MD, Nájera C, De Frutos R. A possible association between the CCK-AR gene and persistent auditory hallucinations in schizophrenia. Eur Psychiatry. 2004 Sep;19(6):349-53. doi: 10.1016/j.eurpsy.2004.06.015. PMID: 15363473.

7. González JC, et al (Sanjuan J.) Persistent auditory hallucinations. Psychopathology. 2006;39(3):120-5. doi: 10.1159/000091796. Epub 2006 Mar 1. PMID: 16531686.

8.Perez-Rando M, et al (Sanjuan J) Alterations in the volume of thalamic nuclei in patients with schizophrenia and persistent auditory hallucinations. Neuroimage Clin. 2022 Jun 1;35:103070. doi: 10.1016/j.nicl.2022.103070. Epub ahead of print. PMID: 35667173; PMCID: PMC9168692.

9.Lorente-Rovira E, et al (Sanjuán J) Different measures for auditory hallucinations in populations with psychosis. The Validation of the Spanish versions of the Auditory Vocal Hallucination Rating Scale (AVHRS) and the Positive and Useful Voices Inquiry (PUVI). Rev Psiquiatr Salud Ment (Engl Ed). 2020 May 31:S1888-9891(20)30027-6. English, Spanish. doi: 10.1016/j.rpsm.2020.03.002. Epub ahead of print. PMID: 32493672.

10.Lorente-Rovira E, et al (Sanjuán J). Positive and Useful Voices in Patients With Schizophrenia: Prevalence, Course, Characteristics, and Correlates. J Nerv Ment Dis. 2020 Aug;208(8):587-592. doi: 10.1097/NMD.0000000000001183. PMID: 32453282.

11.Escarti MJ, et al (Sanjuan J) Auditory hallucinations in first-episode psychosis: A voxel-based morphometry study. Schizophr Res. 2019 Jul;209:148-155. doi: 10.1016/j.schres.2019.05.001. Epub 2019 May 18. PMID: 31113747.

12.Gilabert-Juan J, et al (Sanjuán J) Semaphorin and plexin gene expression is altered in the prefrontal cortex of schizophrenia patients with and without auditory hallucinations. Psychiatry Res. 2015 Oct 30;229(3):850-7. doi: 10.1016/j.psychres.2015.07.074. Epub 2015 Jul 29. PMID: 26243375.

13.de la Iglesia-Vaya M, et al (Sanjuan J) Abnormal synchrony and effective connectivity in patients with schizophrenia and auditory hallucinations. Neuroimage Clin. 2014 Sep 4;6:171-9. doi: 10.1016/j.nicl.2014.08.027. PMID: 25379429; PMCID: PMC4215518.

14.Rubio JM, et al (Sanjuán J) Examining the course of hallucinatory experiences in children and adolescents: a systematic review. Schizophr Res. 2012 Jul;138(2-3):248-54. doi: 10.1016/j.schres.2012.03.012. Epub 2012 Mar 30. PMID: 22464200.

15.García-Martí G,(Sanjuán J). Multimodal morphometry and functional magnetic resonance imaging in schizophrenia and auditory hallucinations. World J Radiol. 2012 Apr 28;4(4):159-66. doi: 10.4329/wjr.v4.i4.159. PMID: 22590670; PMCID: PMC3351684.

16.Rivero O, et al (Sanjuan J). Serotonin transporter gene polymorphisms and auditory hallucinations in psychosis. Rev Neurol. 2010 Mar 16;50(6):325-32. English, Spanish. PMID: 20309830.

17.Martínez-Granados B, et al (Sanjuán J) Spectroscopic metabolomic abnormalities in the thalamus related to auditory hallucinations in patients with schizophrenia. Schizophr Res. 2008 Sep;104(1-3):13-22. doi: 10.1016/j.schres.2008.05.025. Epub 2008 Jul 22. PMID: 18650068.

18.Aguilar EJ, et al (Sanjuan J), MR and genetics in schizophrenia: focus on auditory hallucinations. Eur J Radiol. 2008 Sep;67(3):434-9. doi: 10.1016/j.ejrad.2008.02.046. Epub 2008 Apr 23. PMID: 18436404.

19.García-Martí G, et al (Sanjuán J) Schizophrenia with auditory hallucinations: a voxel-based morphometry study. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jan 1;32(1):72-80. doi: 10.1016/j.pnpbp.2007.07.014. Epub 2007 Jul 19. PMID: 17716795.

20.Martí-Bonmatí L,et al (Sanjuán J). Chronic auditory hallucinations in schizophrenic patients: MR analysis of the coincidence between functional and morphologic abnormalities. Radiology. 2007 Aug;244(2):549-56. doi: 10.1148/radiol.2442060727. PMID: 17641373.

21. Sanjuan J et al Candidate Genes involved in the expression of psychotic symptoms: a focus on hallucinations. In The Neuroscience of Hallucinations. Jardri edit. Springer. 2016.

1. Bonet L, Torous J, Arce D, Blanquer I, Sanjuan J. ReMindCare App for Early Psychosis: Pragmatic Real World Intervention and Usability Study. JMIR Mhealth Uhealth. 2020 Nov 6;8(11):
   https://pubmed.ncbi.nlm.nih.gov/33155986/
2. Bonet L, Llácer B, Hernandez-Viadel M, Arce D, Blanquer I, Cañete C, Escartí M, González-Pinto AM, Sanjuán J. Differences in the Use and Opinions About New eHealth Technologies Among Patients With Psychosis: Structured Questionnaire. JMIR Ment Health. 2018 Jul 25;5(3):e51. doi: 10.2196/mental.9950. PMID: 30045835; PMCID: PMC6083047.
   https://pubmed.ncbi.nlm.nih.gov/30045835/

1. Juckel G, de Bartolomeis A, Gorwood P, Mosolov S, Pani L, Rossi A, Sanjuan J. Towards a framework for treatment effectiveness in schizophrenia. Neuropsychiatr Dis Treat. 2014 Sep 24;10:1867-78. doi: 10.2147/NDT.S61672. PMID: 25285010; PMCID: PMC4181746.
   https://pubmed.ncbi.nlm.nih.gov/25285010/
2. Mauriño J, Sanjúan J, Haro JM, Díez T, Ballesteros J. Impact of depressive symptoms on subjective well-being: the importance of patient-reported outcomes in schizophrenia. Patient Prefer Adherence. 2011;5:471-4.
   https://pubmed.ncbi.nlm.nih.gov/22003284/

3.Aguilar EJ,et al (Sanjuan J)  Corripio I, García-Martí G, Grasa E, Martí-Bonmatí L, Gómez-Ansón B, Sanjuán J, Núñez-Marín F, Lorente-Rovira E, Escartí MJ, Brabban A, Turkington D. Emotional fMR auditory paradigm demonstrates normalization of limbic hyperactivity after cognitive behavior therapy for auditory hallucinations. Schizophr Res. 2018 Mar;193:304-312. doi: 10.1016/j.schres.2017.07.024. Epub 2017 Jul 15. PMID: 28720416.

4.Arango C, et al (Sanjuan J) When the healthcare does not follow the evidence: The case of the lack of early intervention programs for psychosis in Spain. Rev Psiquiatr Salud Ment. 2017

5.Crespo-Facorro B, et al (Sanjuan J) Effectiveness, efficiency and efficacy in the multidimensional treatment of schizophrenia: Rethinking project. Rev Psiquiatr Salud Ment. 2017 Jan-Mar;10(1):4-20. English, Spanish. doi: 10.1016/j.rpsm.2016.09.001. Epub 2016 Oct 22. PMID: 27777062.

6.Juckel G, et al (Sanjuan J) Towards a framework for treatment effectiveness in schizophrenia. Neuropsychiatr Dis Treat. 2014 Sep 24;10:1867-78. doi: 10.2147/NDT.S61672. PMID: 25285010; PMCID: PMC4181746.

7.Montejo AL, et al (Sanjuan J) Análisis de los patrones de prescripción de antipsicóticos en psiquiatría [Analysis of prescription patterns of antipsychotic agents in psychiatry]. Actas Esp Psiquiatr. 2006 Sep-Oct;34(5):323-9. Spanish. PMID: 16991021.

1. Sanjuán J, Tolosa A, Colomer-Revuelta J, Ivorra-Martínez J, Llacer B, Jover M. Factores genéticos en el desarrollo del lenguaje [Genetic factors in the development of language]. Rev Neurol. 2010 Mar 3;50
   https://pubmed.ncbi.nlm.nih.gov/20200835/
2. Ivorra-Martínez J, Gilabert-Juan J, Moltó-Ruiz MD, Sanjuán J. Genética del temperamento en niños [The genetics of child temperament]. Rev Neurol. 2007 Oct 1-15;45(7):418-23.
   https://pubmed.ncbi.nlm.nih.gov/17918108/
3. Ivorra JL,et al ( Sanjuan J)  Gene-environment interaction of child temperament. J Dev Behav Pediatr. 2010 Sep;31(7):545-54. doi: 10.1097/DBP.0b013e3181ee4072. PMID: 20729761.
4. Jover M, et al (, Sanjuan J)  Maternal anxiety following delivery, early infant temperament and mother’s confidence in caregiving. Span J Psychol. 2014 Dec 22;17:E95. doi: 10.1017/sjp.2014.87. PMID: 26055183.
5. Bobes Bascarán MTet al (Sanjuan J.) Adaptación española del EAS Temperament Survey para la evaluación del temperamento infantil Spanish adaptation of the EAS Temperament Survey for the assessment of child temperament]. Psicothema. 2011 Feb;23(1):160-6.  PMID: 21266158.
6. Moriano-Gutierrez A, et al (Sanjuan J) Variables ambientales y geneticas relacionadas con alteraciones en la adquisicion del lenguaje en la infancia [Environmental and genetic variables related with alterations in language acquisition in early childhood]. Rev Neurol. 2017 Jan 1;64(1):31-37.  PMID: 28000910.

1. 1.Alcaide J, Guirado R, Crespo C, Blasco-Ibáñez JM, Varea E, Sanjuan J, Nacher J. Alterations of perineuronal nets in the dorsolateral prefrontal cortex of neuropsychiatric patients. Int J Bipolar Disord. 2019 Nov 15;7(1):24. doi: 10.1186/s40345-019-0161-0. PMID: 31728775; PMCID: PMC6856240.
   https://pubmed.ncbi.nlm.nih.gov/31728775/
2. Castillo-Gómez E, Pérez-Rando M, Bellés M, Gilabert-Juan J, Llorens JV, Carceller H, Bueno-Fernández C, García-Mompó C, Ripoll-Martínez B, Curto Y, Sebastiá-Ortega N, Moltó MD, Sanjuan J, Nacher J. Early Social Isolation Stress and Perinatal NMDA Receptor Antagonist Treatment Induce Changes in the Structure and Neurochemistry of Inhibitory Neurons of the Adult Amygdala and Prefrontal Cortex. eNeuro. 2017 May 1;4(2):ENEURO.0034-17.2017. doi: 10.1523/ENEURO.0034-17.2017. PMID: 28466069; PMCID: PMC5411163.
   https://pubmed.ncbi.nlm.nih.gov/28466069/
3. Sánchez-Pérez AM, García-Avilés Á, Albert Gascó H, Sanjuán J, Olucha-Bordonau FE. Efectos del metilfenidato sobre la ansiedad . Rev Neurol. 2012 Oct 16;55(8):499-506.
   https://pubmed.ncbi.nlm.nih.gov/23055432/

1. Brüne M, Belsky J, Fabrega H, Feierman HR, Gilbert P, Glantz K, Polimeni J, Price JS, Sanjuan J, Sullivan R, Troisi A, Wilson DR. The crisis of psychiatry – insights and prospects from evolutionary theory. World Psychiatry. 2012 Feb;11(1):55-7.
   https://pubmed.ncbi.nlm.nih.gov/22295011/
2. Sanjuan J y Rivero O (2009) Factores de riesgo de los bilógico a lo ambiental En Manual de Psiquiatría. Palomo Jimenes Arriero editores. Madrid.
   https://clea.edu.mx/biblioteca/files/original/19e8cf657df192503cbea09f9f10532d.pdf
3. Sanjuan J ¿Que psiquiatría biológica deben aprender los psiquiatras del futuro?
   https://www.academia.edu/8652822/Qué_Psiquiatr%C3%ADa_biológica_deben_aprender_los_psiquiatras_del_futuro
4. Sanjuan J (2006) Teorías evolucionistas de la esquizofrenia.
   https://www.siicsalud.com/pdf/clavespsiquiatria2_3.pdf
5. Sanjuan J (2006) Agresiones adaptativas y anomalas. Methode.
6. Sanjuan J (2010) Darwinismo y Psiquiatría. Psiquiatría.comhttps://psiquiatria.com/bibliopsiquis/volumen.php?wurl=darwinismo-y-psiquiatria
7. Sanjuan J & Molto MD (2004) Trastornos de Personalidad : Genética y Evolución. En Roca Bennasar Edit. Trastornos de Personalidad. Barcelona. Ars Medica.
8. Sanjuan J. (2009). Teoría de la Evolución en la Medicina. Madrid. Panamericana. 
9. Sanjuan J. (2009) Teorías Evolucionistas. En Vallejo J y Leal C. Edit. Tratado de Psiquiatría (2ªedic). Barcelona. Ars Medica
10. Sanjuan J (2015) Evolución y psicopatología de la teoría a la practica. En Muñoz-Delgado J &Diaz JL, Moreno C. Genealogía de la Mente Humana.Evolución, cerebro y psicopatología. Mexico. Herder. 
11. Sanjuán J, Tolosa A, González JC, et al (2006) Association between FOXP2 polymorphisms and schizophrenia with auditory hallucinations. Psychiatr Genet. 16(2):67-72. 
12. Sanjuán J. & Cases N. (2001) ¿Porque somos vulnerables a la depresión? Pallardo F. Edit. Sociedad Valenciana de Estudios Avanzados. Valencia.  
13. Sanjuán  J. (2002) Neurosis, evolución y cultura: Las neurosis desde una perspectiva evolucionista. En Roca M. Coord. Trastornos Neuróticos. Barcelona. Ars Medica 
14. Sanjuán J. Teorías evolucionistas de las esquizofrenias [Evolutionary theories on schizophrenia]. Actas Esp Psiquiatr. 2000 Dec;28(8):5-12.  PMID: 11262300.
15. Rivero O, et al (Sanjuán J). Impact of the AHI1 gene on the vulnerability to schizophrenia: a case-control association study. PLoS One. 2010 Aug 18;5(8):e12254. doi: 10.1371/journal.pone.0012254. PMID: 20805890; PMCID: PMC2923617.
16. Luengo A, et al (Sanjuán J) Respuesta emocional ante estímulos amenazantes en psicosis y trastornos de ansiedad [Emotional response to threatening stimuli in psychosis and anxiety disorders]. Psicothema.2009 Feb;21(1):51-6. Spanish. PMID: 19178856.

1. Sanjuan J, et al Mood changes after delivery: role of the serotonin transporter gene. Br J Psychiatry. 2008 Nov;193(5):383-8. doi: 10.1192/bjp.bp.107.045427. PMID: 18978318.
2. Gutierrez-Zotes A,et al  (Sanjuan J). Factor Structure of the Spanish Version of the Edinburgh Postnatal Depression Scale. Actas Esp Psiquiatr. 2018 Sep;46(5):174-82. Epub 2018 Sep 1. PMID: 30338774.
3. Gelabert E,et al (Sanjuan J) Vilella E, Martin-Santos R. The role of personality dimensions, depressive symptoms and other psychosocial variables in predicting postpartum suicidal ideation: a cohort study. Arch Womens Ment Health. 2020 Aug;23(4):585-593. doi: 10.1007/s00737-019-01007-w. Epub 2019 Dec 4. PMID: 31802248.
4. Gutiérrez-Zotes A, et al (Sanjuan J). Coping strategies for postpartum depression: a multi-centric study of 1626 women. Arch Womens Ment Health. 2016 Jun;19(3):455-61. doi: 10.1007/s00737-015-0581-5. Epub 2015 Sep 23. PMID: 26399872.
5. Martín-Santos R, et al (Sanjuan J). Research letter: is neuroticism a risk factor for postpartum depression? Psychol Med. 2012 Jul;42(7):1559-65. doi: 10.1017/S0033291712000712. PMID: 22622082; PMCID: PMC3359638.
6. Costas J, et al (Sanjuán J). Association study of 44 candidate genes with depressive and anxiety symptoms in post-partum women. J Psychiatr Res. 2010 Aug;44(11):717-24. doi: 10.1016/j.jpsychires.2009.12.012. Epub 2010 Jan 22. PMID: 20092830.
7. Albacar G,et al (Sanjuan J) Thyroid function 48h after delivery as a marker for subsequent postpartum depression. Psychoneuroendocrinology. 2010 Jun;35(5):738-42. doi: